baber/WOPTO huggingface dataset:
Patent NZ-229929-A (NZ)
Title: 9-(2-valeryloxyethoxymethyl)guanine and antiviral compositions
Inventor: BEAUCHAMP LILIA MARIE
IPC: C07D473/18
Filed: 1989-07-13
Abstract: The present invention relates to the valeryl ester of acyclovir and pharmacologically acceptable salts thereof and their use in medical therapy particularly in the treatment or prophylaxis of viral infections. Also provided are processes for the preparation and pharmaceutical formulations containing the compounds according to the invention.
Patent NZ-234255-A (NZ)
Title: Optically pumped amplifier for fibre optic telecommunication line
Inventor: GRASSO GIORGIO
IPC: H04B17/40
Filed: 1990-06-26
Abstract: An optical fiber telecommunication line according to the invention comprises active core optical fiber amplifiers (6, 7, 8 and 9) of the transmitted signals. Two laser sources (19, 20) of pumping optical radiation are connected to each active core optical fiber present in the amplifiers (6, 7, 8 and 9) of the line, one for each end of a single active core optical fiber. Of these two laser sources (19, 20) of pumping optical radiation the first one (19) is put into service and the second one (20) is kept as reserve to be put into service when the first one fails. Moreover the two pumping optical radiation sources (19, 20) are associated to a microprocessing circuit (29) able to oblige them to send alarm signals about the state of the amplifier to the terminal stations (10, 11) of the line and to received from these latter the control signals for the exchange of functioning between the two pumping optical radiation sources (19, 20).
Patent NZ-237673-A (NZ)
Title: Wood preservative composition incorporating a copper and/or zinc borate, a volatile nitrogenous base and water
Inventor: KAZUNOBU SHIOZAWA
IPC: B27K3/22
Filed: 1991-04-03
Abstract: A wood preservative composition including a preservative component which is selected from the group consisting of copper borate and zinc borate, a volatile basic compound of the formula R3N, wherein R is one of hydrogen atom and lower alkyl group, and water, a process for preserving wood with the wood preservative composition, and a wood preserved with the the wood preservative composition. The wood can be protected from wood attacking organisms for a prolonged period of time without involving environmental pollutions.
Patent NZ-238339-A (NZ)
Title: Use of doxazosin, amlodipine, or u.k.-52,046 for treating erectile impotence in human males
Inventor: MILNE GEORGE MCLEAN
IPC: A61P15/00
Filed: 1991-05-30
Abstract: A method of relieving erectile impotence in a human male. The method comprises administering to the male an erectile impotence relieving amount of a compound selected from the group consisting of U.K. 52,046, Amlodipine, Doxazosin and the pharmaceutically acceptable acid addition salts thereof.
Patent NZ-239780-A (NZ)
Title: Reduced friction fastener; low friction material between threaded hub and thrust disc
Inventor: MATTHEWS NORMAN LESLIE
IPC: F16B37/16
Filed: 1991-09-12
Abstract: PCT No. PCT/AU91/00420 Sec. 371 Date Apr. 30, 1993 Sec. 102(e) Date Apr. 30, 1993 PCT Filed Sep. 12, 1991 PCT Pub. No. WO92/04549 PCT Pub. Date Mar. 19, 1992.A fastener (50) is disclosed suitable for securing a grinding wheel (92) to the spindle of an angle grinder, the fastener (50) being capable of tightening and loosening by hand. The fastener (50) comprises a first disc-shaped component (52) having a first pressure transmitting surface (53) adapted to bear against the grinding wheel (92), and a second disc-shaped component (54) having a threaded hub (56) non-rotatably fixed thereto. The first and second components (52, 54) are assembled on the hub (56) so as to be rotatable with respect to each other, and the second component (54) is adapted to apply an axially directed compressive force to press the first component (52) against the grinding wheel when a torque is applied to the second component (54). A solid dry lubricant washer (62) is provided between facing surfaces of said first and second components (52, 54) in an annular recess (64) immediately adjacent the hub (56), for reducing friction when one of the components ( 52, 54) is rotated relative to the other (54, 52). The lubricant washer (62) can ensure that a significantly increased proportion of the torque applied to the second component (54) is converted to compressive force transmitted through the first component (52) to the grinding wheel (92). A gripping device in the form of a flap (72) is pivotally connected to the second component (54), and is capable of pivoting to an upright position in which the flap (72) can be manually grasped to apply a torque to the fastener.
Patent NZ-242599-A (NZ)
Title: Diagnosing noninsulin-dependent diabetes and the oligonucleotide primers used
Inventor: ULLRICH AXEL
IPC: C12Q1/6881
Filed: 1992-05-04
Abstract: PCT No. PCT/EP92/00949 Sec. 371 Date Nov. 21, 1994 Sec. 102(e) Date Nov. 21, 1994 PCT Filed Apr. 30, 1992 PCT Pub. No. WO92/19769 PCT Pub. Date Nov. 12, 1992To diagnose non-insulin dependent diabetes mellitus or a genetically conditioned disposition thereto, examinations are made of tissue cells, especially skeletal muscle cells, from the person concerned for the presence of the human insulin receptor type B (HIR-B). This examination is preferably conducted with the aid of specific oligonucleotides as primers in a PCR amplification reaction of cDNA obtained from tissue RNA which enables a distinction to be made between HIR-A and HIR-B RNA.
Patent NZ-256614-A (NZ)
Title: Oxygen scavenging polymer composition containing a transition metal catalyst; use in preserving foodstuffs
Inventor: SPEER DREW VE
IPC: B32B27/32
Filed: 1993-09-24
Abstract: A composition for scavenging oxygen is disclosed. The composition comprises an ethylenically unsaturated hydrocarbon polymer which has 0.01-1.0 equivalents of carbon-carbon double bonds per 100 g of polymer and a transition metal catalyst and can be incorporated into various types of layers. The composition has an elongation-at-break of at least 20% and retains at least 50% of its original tensile strength after oxygen scavenging has occurred.
Patent NZ-256679-A (NZ)
Title: Use of parathormone (parathyroid hormone) in prevention and therapy of abortion and of premature birth
Inventor: BAGNOLI FRANCO
IPC: A61P13/02
Filed: 1993-10-08
Abstract: PCT No. PCT/EP93/02755 Sec. 371 Date Apr. 5, 1995 Sec. 102(e) Date Apr. 5, 1995 PCT Filed Oct. 8, 1993 PCT Pub. No. WO94/08613 PCT Pub. Date Apr. 28, 1994Pharmaceutical compositions containing Parathormone as active ingredient, its biologically active fragments and correlated peptides (PTHrP), eventually in combination with appropriate pharmaceutically acceptable additives, useful in the prevention and therapy of abortion and of premature birth and in general for the treatment of pregnancy are described.
Patent NZ-272044-A (NZ)
Title: Process for preparing 1-(het)aryl-3-hydroxypyrazoles from propiolic acid esters and (het)arylhydrazines
Inventor: KONIG HARTMANN
IPC: C07D231/22
Filed: 1995-05-02
Abstract: The prepn. of 1-(Hetero)aryl-3-hydroxy-pyrazoles of formula (I) comprises mixing propiolic acid esters of formula R1C  IDENTICAL CCOOR' (II) with (hetero)arylhydrazine derivs. of formula RNHNH2 (III) in an inert solvent; and then treating with a base at 0-60 degrees C. R = opt. substd. aromatic or heteroaromatic; n = 0, 1 or 2; R1 = a gp. which is stable under the reaction conditions; R' = alkyl, cycloalkyl or aryl.
Patent NZ-280523-A (NZ)
Title: Administering insulin like growth factor i or iii to reduce peripheral neuropathy not caused by abnormal insulin levels
Inventor: LEWIS MICHAEL E
IPC: A61K31/52
Filed: 1993-06-01
Abstract: The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Patent NZ-331302-A (NZ)
Title: Storage wrap material having a peelable portion
Inventor: HAMILTON PETER WORTHINGTON
IPC: C09J201/00
Filed: 1997-01-08
Abstract: The application relates to sheet-like materials suitable for use in the containment and protection of various items, as well as the preservation of perishable materials such as food items.  More particularly, the application provides an improved storage wrap material comprising a sheet of material having a first side and a second side.  The first side comprises an active side exhibiting an adhesion peel force after activation by a user which is greater than an adhesion peel force exhibited prior to activation by a user.  The storage wrap material may be activated by different approaches, but in a preferred embodiment the active side is activatible by an externally applied force exerted upon the sheet of material.  The force may be an externally applied compressive force exerted in a direction substantially normal to the sheet of material. In accordance with the present invention, the storage wrap material is selectively activatible by a user in discrete regions to provide adhesive properties where and when desired.  The use of an adhesive or adhesive-like substance on the surface of the material provides an adhesion peel force, after activation, which is sufficient to form a barrier seal against a target surface at least as great as those of the material and the target surface such that perishable items, such as food items, may be effectively preserved.  The storage wrap materials of the application may be utilized to enclose and protect a wide variety of items by various methods of application, including direct application to the desired item, enclosure of the desired item and securement to itself, and/or in combination with a semi-enclosed container.
Patent NZ-332688-A (NZ)
Title: Stimulation of host defence mechanisms against tumors using interferon
Inventor: TOVEY MICHAEL GERARD
IPC: A61P19/02
Filed: 1997-05-05
Abstract: This use of interferon is in the preparation of a medicament for oromucosal contact, to treat a neoplastic condition, where the medicament comprises 1500 IU - 20x106 IU per day.
Patent NZ-333657-A (NZ)
Title: A pharmaceutical composition comprising cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin
Inventor: ZENKE GERHARD
IPC: A61P29/00
Filed: 1997-07-29
Abstract: The composition comprises a synergistic combination of cyclosporin A and 40-O-(2-hydroxyethyl)-rapamycin. The composition is useful in the treatment and prevention of transplant rejection, certain autoimmune diseases and inflammatory diseases.
Patent NZ-333689-A (NZ)
Title: Support structure for remotely operated camera with support circular base and legs, and extension lengths and connectors of electrically insulated construction
Inventor: FROST ROGER WAYNE
IPC: G03B3/12
Filed: 1997-06-10
Abstract: he present invention relates to a method and apparatus configured to allow photographs to be taken from a number of elevated positions. The invention includes a support structure to provide the variable elevations required for a camera supported by the structure, wherein the support structure includes an extension means capable of extending from a support base, the support structure being characterised in that the extension means is comprised of lengths that are capable of being connected or disconnected from one another to form a single length to provide the variable elevations required for the still photographic camera. Provisions are also made for the remote control and surveillance of a camera elevated by the support structure, and a connector made of electrically insulating material used to join the lengths together in an end-to-end relationship.
Patent NZ-334427-A (NZ)
Title: Low density buoyant products having specific gravity lower than water and each close cell layer having a thickness of 1 mm
Inventor: SARDI GIANLUCA
IPC: A41D31/00
Filed: 1997-08-28
Abstract: Low density semi-finished product for manufacturing buoyant products, comprising a plurality of layers (3) of closed-cell expanded material, having a specific gravity lower than that of water, the layer (3) being flexible and elastic and being joined together by quilting (4, 5) spaced so as to define between them pockets of air, characterised in that the said quilting (4, 5) is preferably distributed in closed patterns.
Patent NZ-334543-A (NZ)
Title: Modified amino acids for production of antibodies and labelled compounds suitable for RIA and ELISA assays
Inventor: RUDOLF KLAUS
IPC: C07D419/12
Filed: 1997-09-08
Abstract: Modified amino acids of general formula (I). Wherein; R is unbranched C1-7alkyl group which may be substituted at the w-position, unbranched C1-6alkylamino group optionally substituted at the nitrogen atom by a C1-6alkyl group or by a phenylmethyl group, which may substituted in the w-position or R is as described in formula (II); Z is -NR1- or a methylene group, wherein R1 is H, C1-7alkyl or phenylC1-2alkyl group; m is 0 nor 1; n is 1 or 2; R2 is an aromatic or heteroaromatic group optionally mono-, di- or tri-substituted in the carbon skeleton by F, Cl or Br, by C1-6alkyl groups, C1-6alkoxy, trifluormethyl, C1-4alkoxycarbonyl, carboxy, OH, nitro or amino groups; R11 is H or C1-3alkyl group; X is oxygen or 2 hydrogen atoms; A is shown as Formula (III), wherein R8 and R9 together are n-propylene group, R8 is H, alkyl or phenyl group, R9 is H or branched and unbranched C1-5alkyl group substituted in the w-position; R3 is H, C1-7alkyl group substituted at the w-position, a phenyl or pyridinyl group; R4 is H or C1-3alkyl group optionally substituted by a phenyl or pyridinyl group; or R3 and R4 together form the compound shown in Formula (IV), wherein Y3 is carbon, if R12 is a free pair of electron, Y3 may also be nitrogen, r is 0-2, q is 0-2, R10 is H , amino, alkylamino, dialkylamino, alkyl, cycloalkyl, alkylaminoalkyl, dialkylaminoalkyl, alkylaminocarbonylamino, cycloalkylaminocarbonylamino, phenylaminocarbonylamino, aminocarbonylalkyl, aminocarbonylaminoalkyl, alkoxycarbonyl, alkoxycarbonylalkyl, carboxy group or 1,1-dioxido-3(4H)-oxo-1,2,4-benzothiadiazin-2-yl group, R12 is H, C1-4alkyl, alkoxycarbonyl, cyano or aminocarbonyl, R13 and R14 is H. The method and use for the production and purification of antibodies and as marked compounds in RIA and ELISA assays and as diagnostic or analytic auxiliary agents in neurotransmitter research are described. The pharmaceutical composition is suitable for acute and prophylactic treatment of headaches, for treating non-insulin dependent diabetes melitis, cardiovascular disorders, skin diseases, inflammatory disease, allergic rhinitis asthma, disease accompanied by excessive vasodilation and consequently reduced blood circulation, e.g. shock and sepsis, and morphine tolerance.
Patent NZ-337527-A (NZ)
Title: Water-soluble pharmaceutical composition comprising an ionic complex of a polypeptide and an amphiphilic compound and a method for increasing the activity of a polypeptide by forming the aforementioned complex
Inventor: PAPADIMITRIOU APOLLON
IPC: A61K45/00
Filed: 1999-08-27
Abstract: An aqueous composition containing a pharmaceutically effective polypeptide selected from the group consisting of hedgehog proteins, bone morphogenetic proteins, growth factors, erythropoietin, thrombopoietin, G-CSF, interleukins and interferons, characterized in that the composition contains, in addition, an amphiphilic compound, the polypeptide and the amphiphilic compound forming an ionic complex, whereby the forming of the complex does not increase the solubility of the protein. These complexes compositions increase the activity of the polypeptide.
Patent NZ-337978-A (NZ)
Title: Hydrodynamic electroprocessing of soluble conducting polymers
Inventor: WALLACE GORDON GEORGE
IPC: C25B3/29
Filed: 1998-02-27
Abstract: A process for preparing a soluble conductive polymer includes electrochemically polymerising a monomer and/or an oligomer, or two or more different monomers and/or oligomers, in an electrolytic cell. The monomer and/or oligomer solution flows hydrodynamically through the half-cell from inlet 6, through the electrode 3, and out of the cell via outlet 7, and an electrolyte similarly flows through the half-cell 2 from the inlet 8 to outlet 9 via the counter electrode 4.  The half-cells are separated by membrane 5 and conductors 11 supply the electrodes with current from a controller.
Patent NZ-501729-A (NZ)
Title: Veneer cutting machine and nose bar device therefor
Inventor: MASARU KOIKE
IPC: B27L5/02
Filed: 1999-12-10
Abstract: A nose bar device 21 in a rotary veneer lathe for peeling a wood veneer sheet from a rotating log 11 is claimed.  The lathe has a knife carriage movable toward and away from log 11 and a knife 17 is mounted on the knife carriage and has at the tip end thereof, a cutting edge 17a extending horizontally across the direction in which knife carriage is moved.  A plurality of nose bars 21 are juxtaposed along cutting edge 17a of knife 17 mounted to a part of the knife carriage and each has at the lower end thereof a pressure edge located adjacent to the cutting edge of knife and has a width extending in parallel to the cutting edge of knife for pressing against the log adjacent to the cutting edge of knife 17.  The nose bar mounting part of the knife carriage is movable independently of the knife carriage and a mechanism 29 for independently adjustably moving the pressure edge of at least one of nose bars toward and away from the cutting edge of knife 17, is clamed.
Patent NZ-503043-A (NZ)
Title: Poly(ADP-ribose) polymerase (PARP) inhibitors for treating neural or cardiovascular tissue damage
Inventor: MACLIN KEITH M
IPC: A61P17/00
Filed: 1998-09-02
Abstract: Compounds shown and compounds of formula (I) wherein: Y is a direct bond, O, NR11, CR6 or CH-COOC. R11 and R6 are H or CH3; Z is O, S or NH; X is NH, O, S, CH2, a bond, -CH=CH- or -CH2-CH2-; R1-R7 are independently: hydrogen, amino, alkylamino, nitro, nitroso or a 5- or 6- membered N- containing heterocycle that is bonded via its N-atom. The compounds are useful for inhibiting Poly(ADP-ribose) polymerase (PARP) inhibitors activity and treating diseases or disorders including tissue damage resulting from cell damage or death due to necrosis or apoptosis, neuronal mediated tissue damage or diseases, neural tissue damage resulting from ischemia and reperfusion injury, neurological disorders and neurodegenerative diseases, vascular stroke, cardiovascular disorders, age-related macular degeneration, AIDS and other immune senescence diseases, arthritis, atherosclerosis, cachexia, cancer, degenerative diseases of skeletal muscle involving replicative senescence, diabetes, head trauma, immune senescence, inflammatory bowel disorders, muscular dystrophy, osteoarthritis, osteoporosis, chronic pain, acute pain, neuropathic pain, nervous insult, peripheral nerve injury, renal failure, retinal ischemia, septic shock, and skin aging, diseases or disorders relating to lifespan or proliferative capacity of cells, and diseases or disease conditions induced or exacerbated by cellular senescence.
Patent NZ-507584-A (NZ)
Title: Container systems for floral arrangements having water reservoir and porous insert
Inventor: KEATING KEVIN
IPC: B65D85/50
Filed: 1999-04-08
Abstract: A container system for a floral arrangement, comprising a waterproof container having a base portion which can act as a water reservoir, and a separate insert locatable from above into a lower part of the container, the insert acting to confine from above water within the reservoir, the insert carrying a porous water-retaining material lying within the reservoir, the porous material extending upwardly through the insert so that an upper portion of the material is exposed to receive the stems of cut flowers and the like.
Patent NZ-508229-A (NZ)
Title: Hydroxamic acid derivatives as inhibitors of the production of human soluble CD23 and the TNF release for treating autoimmune diseases or allergies
Inventor: FALLER ANDREW
IPC: C07C259/06
Filed: 1999-06-22
Abstract: The compound of formula (I) is described, wherein: R is methyl substituted by one to three groups selected from alkyl, aryl, alkenyl and alkenyl; n is 0 or 1; R1 is arylmethyl or heterocyclylmethyl; R2 is alkyl, alkenyl, aryl, cycloalkyl or cycloalkenyl; and R3 is hydrogen, alkyl, alkenyl or aryl. The compound can be used in a pharmaceutical composition for the treatment or prophylaxis of disorders such as allergy, inflammatory disorders and autoimmune diseases in which the overproduction of s-CD23 is implicated. Also described is a process of preparing the compound
Patent NZ-511759-A (NZ)
Title: Thermostable enzyme promoting the fidelity of thermostable DNA polymerases- for improvement of nucleic acid synthesis and amplification in vitro
Inventor: LAUE FRANK
IPC: C12Q1/686
Filed: 2000-09-27
Abstract: Thermostable enzyme exhibiting 3'-exonuclease-activity but essentially no DNA polymerase activity where the enzyme enhances fidelity of an amplification process when added to a second enzyme exhibiting polymerase activity, where the thermostable enzyme is obtained from Archeoglobus fulgidus. Also described is a method of preparing or amplifying DNA using the above-described composition. Also described is a method for amplifying DNA using a thermostable enzyme exhibiting 3'-exonuclease-activity but essentially no DNA polymerase activity and obtained from Archeoglobus fulgidus which enzyme is not or only to a negligible extent active on linear single stranded DNA.
Patent NZ-512172-A (NZ)
Title: Plant container
Inventor: MATTHEWS PHILLIP LINDSAY
IPC: A01G9/02
Filed: 1999-11-05
Abstract: A plant container (22) formed of two readily releasable half-container parts, each part having a plant container portion (38). The two parts combine to define there between an opening (28) adapted to permit access of any plant growth (16) extending from beneath the plant container (22). The plant container (22) is adapted to be located adjacent the upper portion of a conventional plant hire container arrangement of an outer decorative container (4) housing an inner plant container (6).
Patent NZ-519171-A (NZ)
Title: Beverage multiple packaging lock system
Inventor: SUTHERLAND ROBERT L
IPC: B65D5/42
Filed: 2001-10-11
Abstract: This invention relates to a primary and secondary locking system for wrap-around carriers (10). A secondary male lock (60A-C) is held in the vertical position by a female door flap (66A-C) leaning against the male lock.
Patent NZ-520769-A (NZ)
Title: Truck streamlining
Inventor: STEEL KENNETH
IPC: B62D35/00
Filed: 2002-11-26
Abstract: A leading edge aerofoil (7) for reducing drag on a truck (1) carrying or towing at least one bluff body (3,5) is disclosed. The aerofoil has a curved nose with an upper surface angling away from the nose and a lower surface extending rearwardly from the nose. The profile of the aerofoil is such that the vertical distance from the top of the upper surface to the most forward point of the nose is greater than the vertical distance from the forward point of the nose to the lowest point of the lower surface. The aerofoil is configured for attachment to the most forward bluff body of the load (3) or to the top of the tractor unit (1) such that the aerofoil assists in attaching oncoming airflow to the upper surface of the forward bluff body of the load, thereby reducing drag. Further disclosed is a set of aerofoils including the leading edge aerofoil described above, with an additional trailing edge aerofoil (11) on the rearmost bluff body and, if applicable, an intermediate aerofoil (9) configured to direct the airflow between bluff bodies of the load in order to reduce drag.